Epizyme is a company headquartered in the United States.
Epizyme is a biopharmaceutical company focused on developing and commercializing novel epigenetic medicines for patients with cancer and other serious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.